EUVIMEDEUVIMED entdecken
Crossref

Performance of CO ‐ RADS in the diagnosis of COVID ‐19 in hemodialysis patients

Pervin Ozkan Kurtgoz iD, Fatih Sackan iD, Meral Buyukterzi iD, Ibrahim Guney iD

Therapeutic Apheresis and Dialysis · 2025

DOI: 10.1111/1744-9987.14215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2025. Verfasst von Pervin Ozkan Kurtgoz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, University of Health Sciences, Konya City Hospital, Konya, Turkey. Hauptthemen laut MEDLINE: COVID-19, Renal Dialysis, Tomography, X-Ray Computed. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Different data systems have been used to reach a common decision in the interpretation of chest computed tomography (CT) scans for the detection of COVID‐19 infection. The aim of our study was to determine the usefulness of the COVID‐19 Reporting and Data System (CO‐RADS) for COVID‐19 in patients undergoing hemodialysis.

Methods

We included 90 hemodialysis patients who underwent chest CT and had samples available for real‐time reverse transcription‐polymerase chain reaction (RT‐PCR). The files of the patients were retrospectively reviewed and the data were recorded. Image interpretation and CO‐RADS staging were performed retrospectively by two radiologists experienced in COVID‐19 patients, blinded to the RT‐PCR results. The RT‐PCR results were then compared with the CO‐RADS stages obtained. The success of CO‐RADS in diagnosing COVID‐19 was evaluated according to its prediction of a positive RT‐PCR result. At the same time, the relationship between CO‐RADS stages and prognosis was also evaluated.

Results

Patients were divided into two groups according to the RT‐PCR results, of which 38 (42.2%) had positive results. Validity tests of CO‐RADS were performed according to the RT‐PCR test. While 71.1% of patients with CO‐RADS ≥4 were RT‐PCR (+), 13.2% of patients with CO‐RADS ≤2 were RT‐PCR (+) ( p < 0.001). CO‐RADS ≥4 detected COVID‐19 with 71.1% sensitivity and 51.9% specificity. ROC analysis confirmed the diagnostic performance of CO‐RADS for predicting RT‐PCR positivity with AUC = 0.73 (95% CI: 0.63–0.84). The relationship between CO‐RADS stages and mortality was not significant ( p = 0.21).

Conclusion

CO‐RADS is moderately sensitive and poorly specific for the diagnosis of COVID‐19 in hemodialysis patients. In these patients, CO‐RADS would be more useful to exclude other infections than to diagnose COVID‐19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Renal DialysisTomography, X-Ray ComputedHumansMaleFemaleRetrospective StudiesMiddle AgedAgedSensitivity and SpecificityPrognosisAged, 80 and overAdultSARS-CoV-2Real-Time Polymerase Chain Reaction

Stichwörter der Autor:innen

COVID‐19CO‐RADShemodialysisperformance

Autor:innen und Institutionen

  • Division of Nephrology, Department of Internal Medicine, University of Health Sciences, Konya City Hospital, Konya, Turkey.
  • Department of Internal Medicine, University of Health Sciences, Konya City Hospital, Konya, Turkey.
  • Department of Radiology, University of Health Sciences, Konya City Hospital, Konya, Turkey.

ORCID-Profile: Pervin Ozkan Kurtgoz, Fatih Sackan, Meral Buyukterzi, Ibrahim Guney

Zitieren

APA

Ozkan Kurtgoz, P., Sackan, F., Buyukterzi, M., & Guney, I. (2025). Performance of CO ‐ RADS in the diagnosis of COVID ‐19 in hemodialysis patients. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14215

Vancouver

Ozkan Kurtgoz P, Sackan F, Buyukterzi M, Guney I. Performance of CO ‐ RADS in the diagnosis of COVID ‐19 in hemodialysis patients. Therapeutic Apheresis and Dialysis. 2025. doi:10.1111/1744-9987.14215

BibTeX
@article{OzkanKurtgoz2025,
  author = {Ozkan Kurtgoz, Pervin and Sackan, Fatih and Buyukterzi, Meral and Guney, Ibrahim},
  title = {Performance of CO ‐ RADS in the diagnosis of COVID ‐19 in hemodialysis patients},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2025},
  doi = {10.1111/1744-9987.14215}
}
Kostenlos starten →